Le Lézard
Classified in: Health
Subject: PER

CenExel Leads Industry in Psychiatric Studies at Atlanta Center for Medical Research


SALT LAKE CITY, Jan. 16, 2020 /PRNewswire/ -- CenExel Clinical Research recently strengthened its psychiatric team with the recruitment of Mark N. Lerman, MD, to serve as a principal investigator for phase I-IV studies at the Atlanta Center for Medical Research (ACMR), a CenExel Center of Excellence. ACMR is a well-recognized leader in clinical research and focuses primarily on studies involving central nervous system disorders. Dr. Lerman joins three other principal investigators and six sub-investigators, each with decades of experience.

The physician investigators with specialized focus on psychiatry now include Robert A. Riesenberg, MD, Mahendra Dave, MD, and Mark N. Lerman, MD. With over 40 years of experience spanning more than 1,700 studies, Dr. Riesenberg is ACMR's medical director and serves on the CenExel Psychiatric Advisory Board. Dr. Dave, Distinguished Fellow of the American Psychiatric Association, has over 20 years of clinical trial experience, and has been the lead author on several industry books, including Laboratory Values in Psychiatry Clinical Trials. Dr. Lerman has more than 25 years of experience, almost entirely in psychiatric medical research, conducting over 300 studies. He has also joined CenExel's Psychiatric Advisory Board.

"Recruiting Dr. Mark Lerman to the team makes ACMR even more of a powerhouse in psychiatric medical research," said Eric Riesenberg, CEO of ACMR. "We're excited to build on his amazing background in both psychiatry and the clinical trial field."

"At ACMR, I find myself surrounded by a strong team with a firm devotion to patients and clinical research," said Dr. Lerman. "I'm honored to be a part of such a center of excellence."

In addition to a robust professional staff, ACMR enjoys the largest facility of its kind for private research, specializing in recruiting pediatric, adult, and geriatric psychiatric studies. ACMR also relies on unique facility perks to provide a reliable and consistent psychiatric clinical trial experience.

Media Contact: [email protected]

About CenExel Clinical Research
CenExel Clinical Research (www.CenexelResearch.com) provides unparalleled medical and scientific support in the design and execution of clinical trials. The attention to detail assures quality, reliable results and has helped CenExel to consistently achieve and exceed patient recruitment goals. CenExel Centers of Excellence have conducted thousands of studies, the variety and complexity of which have resulted in depth of experience, insight, and tenure of the principal investigators and research staff in each facility. The CenExel Centers of Excellence deliver the expertise, engagement, and results to ensure that their clients achieve their clinical research goals.

About the Atlanta Center for Medical Research
ACMR (www.acmr.org) is a fully dedicated 100,000 square foot, state-of-the-art research facility. We provide conscientious, recruitment-driven medical research services that are pivotal in the advancement and treatment of illnesses of the central nervous system and other therapeutic areas. Our dedicated and experienced research teams conduct clinical trials with compassion and respect for our research participants. We are a CenExel Center of Excellence, assuring unparalleled patient engagement, staff expertise, and valuable results.

SOURCE CenExel Clinical Research, Inc.


These press releases may also interest you

at 22:03
The report titled "Anti-Mullerian Hormone Test Market by Product (POC Testing, Self-check Kits), End-User (Commercial Labs, Research & development), Distribution, Use - Global Forecast 2024-2030" is now available on 360iResearch.com's offering,...

at 20:40
Rakovina Therapeutics Inc. a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response technologies announced the financial results for its fourth quarter and fiscal year ending December 31, 2023 and...

at 19:40
ReNAgade Therapeutics, a company unlocking the limitless potential for RNA medicines, today announced its ongoing commitment to exploring the therapeutic opportunity of glycobiology through support for ongoing research at GanNA Bio, and the...

at 19:05
Appili Therapeutics Inc. (the "Company" or "Appili"), a biopharmaceutical company focused on drug development for infectious diseases and medical countermeasures, today announced it has secured additional bridge financing in the amount of C$300,000...

at 19:00
David J. Dykeman, co-chair of the Life Sciences & Medical...

at 18:30
Aspire Health Alliance ("Aspire Health") is a company headquartered in Braintree, Massachusetts, that provides behavioral health services in the community.  Aspire Health experienced a data security incident that may have involved personal and...



News published on and distributed by: